MBRX
Moleculin Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.19
+16.79%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-261.7%
Return on equity
-143.8%
Return on assets
-243.1%
Return on invested capital
0.00x
Asset turnover
-$25.4M
Cash from operations
$0.36
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026